ASPC 2020 Virtual Summit on CVD Prevention
Genetic Testing in Preventive Cardiology: Are Those With FH Mutation, for Any Given Observed LDL, at Higher Risk for CAD? Who to Test for FH, and What Are the Ordering Considerations?
By
ASPC 2020 Virtual Summit on CVD Prevention
FEATURING
Amit Khera
By
ASPC 2020 Virtual Summit on CVD Prevention
FEATURING
Amit Khera
Login to view comments.
Click here to Login